Home HIV	FAQ My Amedeo About	Flying Publisher
	Amedeo Prize 2008 The 21 Finalists

Leukemia

Free Subscription Articles published in Br J Haematol Retrieve available abstracts of 207 articles: HTML format

Single Articles

April 2008
1. 
   Abstracts of the British Society of Haematology 48th Annual Scientific Meeting, Incorporating the 6th Bi-Annual I-BFM Leukaemia Symposium. April 7-9, 2008.
   Br J Haematol. 2008;141 Suppl 1:1-121.
   PubMed     Related articles   
   
   
   February 2008
2. SMITH SM , Grinblatt D, Johnson JL, Niedzwiecki D, et al
   Thalidomide has limited single-agent activity in relapsed or refractory indolent non-Hodgkin lymphomas: a phase II trial of the Cancer and Leukemia Group B.
   Br J Haematol. 2008;140:313-319.
   PubMed     Related articles    Abstract available
   
   
   
3. PEREZ A , Gonzalez-Vicent M, Ramirez M, Sevilla J, et al
   Intentional induction of mixed haematopoietic chimerism as platform for cellular therapy after HLA-matched allogeneic stem cell transplantation in childhood leukaemia patients.
   Br J Haematol. 2008;140:340-3.
   PubMed     Related articles    Abstract available
   
   
   
4. TIBES R , Kornblau SM, Qiu Y, Mousses SM, et al
   PI3K/AKT pathway activation in acute myeloid leukaemias is not associated with AKT1 pleckstrin homology domain mutation.
   Br J Haematol. 2008;140:344-7.
   PubMed     Related articles    Abstract available
   
   
   
5. HAMBLIN TJ , Davis ZA, Oscier DG
   Determination of how many immunoglobulin variable region heavy chain mutations are allowable in unmutated chronic lymphocytic leukaemia - long-term follow up of patients with different percentages of mutations.
   Br J Haematol. 2008;140:320-3.
   PubMed     Related articles    Abstract available
   
   
   
6. BLEEKER WK , Munk ME, Mackus WJ, van den Brakel JH, et al
   Estimation of dose requirements for sustained in vivo activity of a therapeutic human anti-CD20 antibody.
   Br J Haematol. 2008;140:303-12.
   PubMed     Related articles    Abstract available
   
   
   
7. ANTEN S , Heddema ER, Visser O, Zweegman AS, et al
   Images in haematology. Cerebral fungal abscess in a patient with acute promyelocytic leukaemia.
   Br J Haematol. 2008;140:253.
   PubMed     Related articles   
   
   
   
8. NGO N , Lampert IA, Naresh KN
   Bone marrow trephine findings in acute myeloid leukaemia with multilineage dysplasia.
   Br J Haematol. 2008;140:279-86.
   PubMed     Related articles    Abstract available
   
   
   
9. SUJOBERT P , Bardet V, Bienvenu M
   Images in haematology. Bilateral adrenal chloromas.
   Br J Haematol. 2008;140:254.
   PubMed     Related articles   
   
   
   January 2008
10. ISKEN F , Steffen B, Merk S, Dugas M, et al
    Identification of acute myeloid leukaemia associated microRNA expression patterns.
    Br J Haematol. 2008;140:153-61.
    PubMed     Related articles    Abstract available
    
    
    
11. OWEN C , Barnett M, Fitzgibbon J
    Familial myelodysplasia and acute myeloid leukaemia--a review.
    Br J Haematol. 2008;140:123-32.
    PubMed     Related articles    Abstract available
    
    
    
12. ROSENBERG PS , Alter BP, Link DC, Stein S, et al
    Neutrophil elastase mutations and risk of leukaemia in severe congenital neutropenia.
    Br J Haematol. 2008;140:210-3.
    PubMed     Related articles    Abstract available
    
    
    
13. KURODA J , Kimura S, Andreeff M, Ashihara E, et al
    ABT-737 is a useful component of combinatory chemotherapies for chronic myeloid leukaemias with diverse drug-resistance mechanisms.
    Br J Haematol. 2008;140:181-90.
    PubMed     Related articles    Abstract available
    
    
    
14. GUINN BA , Bullinger L, Thomas NS, Mills KI, et al
    SSX2IP expression in acute myeloid leukaemia: an association with mitotic spindle failure in t(8;21), and cell cycle in t(15;17) patients.
    Br J Haematol. 2008;140:250-1.
    PubMed     Related articles   
    
    
    
15. BULLEY S , Gassas A, Dupuis LL, Aplenc R, et al
    Inferior outcomes for overweight children undergoing allogeneic stem cell transplantation.
    Br J Haematol. 2008;140:214-7.
    PubMed     Related articles    Abstract available
    
    
    
16. RATTHE C , Girard D
    Investigation of the interleukin (IL)-4/IL-4 receptor system in promyelocytic leukaemia PLB-985 cells during differentiation toward neutrophil-like phenotype: mechanism involved in IL-4-induced SOCS3 protein expression.
    Br J Haematol. 2008;140:59-70.
    PubMed     Related articles    Abstract available
    
    
    
17. GABELLONI ML , Borge M, Galletti J, Canones C, et al
    SHIP-1 protein level and phosphorylation status differs between CLL cells segregated by ZAP-70 expression.
    Br J Haematol. 2008;140:117-9.
    PubMed     Related articles   
    
    
    
18. REDDY N , Hernandez-Ilizaliturri FJ, Deeb G, Roth M, et al
    Immunomodulatory drugs stimulate natural killer-cell function, alter cytokine production by dendritic cells, and inhibit angiogenesis enhancing the anti-tumour activity of rituximab in vivo.
    Br J Haematol. 2008;140:36-45.
    PubMed     Related articles    Abstract available
    
    
    
19. WHITTLE AM , Howard MR
    Skin lesions in plasmacytoid dendritic cell leukaemia.
    Br J Haematol. 2008;140:121.
    PubMed     Related articles   
    
    
    
20. KIM DH , Lee NY, Lee MH, Sohn SK, et al
    Vascular endothelial growth factor (VEGF) gene (VEGFA) polymorphism can predict the prognosis in acute myeloid leukaemia patients.
    Br J Haematol. 2008;140:71-9.
    PubMed     Related articles    Abstract available
    
    
    
21. GASSAS A , Ishaqi MK, Afzal S, Dupuis A, et al
    Outcome of haematopoietic stem cell transplantation for paediatric acute lymphoblastic leukaemia in third complete remission: a vital role for graft-versus-host-disease/ graft-versus-leukaemia effect in survival.
    Br J Haematol. 2008;140:86-9.
    PubMed     Related articles    Abstract available
    
    
    December 2007
22. HARDY NM , Grady C, Pentz R, Stetler-Stevenson M, et al
    Bioethical considerations of monoclonal B-cell lymphocytosis: donor transfer after haematopoietic stem cell transplantation.
    Br J Haematol. 2007;139:824-31.
    PubMed     Related articles    Abstract available
    
    
    
23. GOLDIN LR , Caporaso NE
    Family studies in chronic lymphocytic leukaemia and other lymphoproliferative tumours.
    Br J Haematol. 2007;139:774-9.
    PubMed     Related articles    Abstract available
    
    
    
24. SHAPIRO HM
    Cytometry in monoclonal B-cell lymphocytosis and chronic lymphocytic leukaemia--the Hunting of the Snark?
    Br J Haematol. 2007;139:772-3.
    PubMed     Related articles    Abstract available
    
    
    
25. SLAGER SL , Kay NE, Fredericksen ZS, Wang AH, et al
    Susceptibility genes and B-chronic lymphocytic leukaemia.
    Br J Haematol. 2007;139:762-71.
    PubMed     Related articles    Abstract available
    
    
    
26. RAWSTRON AC , Bennett F, Hillmen P
    The biological and clinical relationship between CD5+23+ monoclonal B-cell lymphocytosis and chronic lymphocytic leukaemia.
    Br J Haematol. 2007;139:724-9.
    PubMed     Related articles    Abstract available
    
    
    
27. LANDGREN O , Kyle RA
    Multiple myeloma, chronic lymphocytic leukaemia and associated precursor diseases.
    Br J Haematol. 2007;139:717-23.
    PubMed     Related articles    Abstract available
    
    
    
28. NICOLOSO MS , Kipps TJ, Croce CM, Calin GA, et al
    MicroRNAs in the pathogeny of chronic lymphocytic leukaemia.
    Br J Haematol. 2007;139:709-16.
    PubMed     Related articles    Abstract available
    
    
    
29. MARTI G , Abbasi F, Raveche E, Rawstron AC, et al
    Overview of monoclonal B-cell lymphocytosis.
    Br J Haematol. 2007;139:701-8.
    PubMed     Related articles    Abstract available
    
    
    
30. VOGT RF , Shim YK, Middleton DC, Buffler PA, et al
    Monoclonal B-cell lymphocytosis as a biomarker in environmental health studies.
    Br J Haematol. 2007;139:690-700.
    PubMed     Related articles    Abstract available
    
    
    
31. VOGT RF , Marti GE
    Overview of monoclonal gammopathies of undetermined significance.
    Br J Haematol. 2007;139:687-9.
    PubMed     Related articles    Abstract available
    
    
    
32. LINET MS , Schubauer-Berigan MK, Weisenburger DD, Richardson DB, et al
    Chronic lymphocytic leukaemia: an overview of aetiology in light of recent developments in classification and pathogenesis.
    Br J Haematol. 2007;139:672-86.
    PubMed     Related articles    Abstract available
    
    
    
33. MCMASTER ML , Caporaso N
    Waldenstrom macroglobulinaemia and IgM monoclonal gammopathy of undetermined significance: emerging understanding of a potential precursor condition.
    Br J Haematol. 2007;139:663-71.
    PubMed     Related articles    Abstract available
    
    
    
34. SHIM YK , Silver SR, Caporaso NE, Marti GE, et al
    B cells behaving badly.
    Br J Haematol. 2007;139:658-62.
    PubMed     Related articles    Abstract available
    
    
    
35. CAPORASO N , Goldin L, Plass C, Calin G, et al
    Chronic lymphocytic leukaemia genetics overview.
    Br J Haematol. 2007;139:630-4.
    PubMed     Related articles    Abstract available
    
    
    
36. RAWSTRON AC , Jones RA, Ferguson C, Hughes G, et al
    Outreach monitoring service for patients with indolent B-cell and plasma cell disorders: a UK experience.
    Br J Haematol. 2007;139:845-8.
    PubMed     Related articles    Abstract available
    
    
    
37. RACHEL JM , Zucker ML, Fox CM, Plapp FV, et al
    Monoclonal B-cell lymphocytosis in blood donors.
    Br J Haematol. 2007;139:832-6.
    PubMed     Related articles    Abstract available
    
    
    
38. BLAIR A , Purdue MP, Weisenburger DD, Baris D, et al
    Chemical exposures and risk of chronic lymphocytic leukaemia.
    Br J Haematol. 2007;139:753-61.
    PubMed     Related articles    Abstract available
    
    
    
39. PLASS C , Byrd JC, Raval A, Tanner SM, et al
    Molecular profiling of chronic lymphocytic leukaemia: genetics meets epigenetics to identify predisposing genes.
    Br J Haematol. 2007;139:744-52.
    PubMed     Related articles    Abstract available
    
    
    
40. AUER RL , Gribben J, Cotter FE
    Emerging therapy for chronic lymphocytic leukaemia.
    Br J Haematol. 2007;139:635-44.
    PubMed     Related articles    Abstract available
    
    
    
41. JOHNSON AJ , Wagner AJ, Cheney CM, Smith LL, et al
    Rituximab and 17-allylamino-17-demethoxygeldanamycin induce synergistic apoptosis in B-cell chronic lymphocytic leukaemia.
    Br J Haematol. 2007;139:837-44.
    PubMed     Related articles    Abstract available
    
    
    
42. SCAGLIONE BJ , Salerno E, Balan M, Coffman F, et al
    Murine models of chronic lymphocytic leukaemia: role of microRNA-16 in the New Zealand Black mouse model.
    Br J Haematol. 2007;139:645-57.
    PubMed     Related articles    Abstract available
    
    
    
43. LANDGREN O , Gridley G, Check D, Caporaso NE, et al
    Acquired immune-related and inflammatory conditions and subsequent chronic lymphocytic leukaemia.
    Br J Haematol. 2007;139:791-8.
    PubMed     Related articles    Abstract available
    
    
    
44. ABBASI F , Longo NS, Lipsky PE, Raveche E, et al
    B-cell repertoire and clonal analysis in unaffected first degree relatives in familial chronic lymphocytic leukaemia kindred.
    Br J Haematol. 2007;139:820-3.
    PubMed     Related articles    Abstract available
    
    
    
45. SCHUBAUER-BERIGAN MK , Daniels RD, Fleming DA, Markey AM, et al
    Chronic lymphocytic leukaemia and radiation: findings among workers at five US nuclear facilities and a review of the recent literature.
    Br J Haematol. 2007;139:799-808.
    PubMed     Related articles    Abstract available
    
    
    November 2007
46. TROEGER A , Gudowius S, Escherich G, den Boer ML, et al
    High nerve growth factor receptor (p75NTR) expression is a favourable prognostic factor in paediatric B cell precursor-acute lymphoblastic leukaemia.
    Br J Haematol. 2007;139:450-7.
    PubMed     Related articles    Abstract available
    
    
    
47. STEENSMA DP , Porcher JC, Hanson CA, Lathrop CL, et al
    Prevalence of erythrocyte haemoglobin H inclusions in unselected patients with clonal myeloid disorders.
    Br J Haematol. 2007;139:439-42.
    PubMed     Related articles    Abstract available
    
    
    
48. MADDOCKS-CHRISTIANSON K , Slager SL, Zent CS, Reinalda M, et al
    Risk factors for development of a second lymphoid malignancy in patients with chronic lymphocytic leukaemia.
    Br J Haematol. 2007;139:398-404.
    PubMed     Related articles    Abstract available
    
    
    
49. SHEIKHOLESLAMI MR , Ma W, Uyeji J, Tornyos K, et al
    Bi-clonal disease in patients with chronic lymphocytic leukaemia as detected by analysing IGHV mutation status.
    Br J Haematol. 2007;139:507-9.
    PubMed     Related articles   
    
    
    
50. BACCHU S , Fegan C, Neal J
    Cerebral toxoplasmosis in a patient with chronic lymphocytic leukaemia treated with fludarabine.
    Br J Haematol. 2007;139:349.
    PubMed     Related articles   
    
    
    
51. GARRATTY G , Petz LD
    Direct antiglobulin test negative autoimmune haemolytic anaemia associated with fludarabine/cyclophosphamide/rituximab therapy.
    Br J Haematol. 2007;139:622-3.
    PubMed     Related articles   
    
    
    
52. BENNETT F , Rawstron A, Plummer M, de Tute R, et al
    B-cell chronic lymphocytic leukaemia cells show specific changes in membrane protein expression during different stages of cell cycle.
    Br J Haematol. 2007;139:600-4.
    PubMed     Related articles    Abstract available
    
    
    
53. NATONI A , MacFarlane M, Inoue S, Walewska R, et al
    TRAIL signals to apoptosis in chronic lymphocytic leukaemia cells primarily through TRAIL-R1 whereas cross-linked agonistic TRAIL-R2 antibodies facilitate signalling via TRAIL-R2.
    Br J Haematol. 2007;139:568-77.
    PubMed     Related articles    Abstract available
    
    
    
54. OSHIMI K
    Progress in understanding and managing natural killer-cell malignancies.
    Br J Haematol. 2007;139:532-44.
    PubMed     Related articles    Abstract available
    
    
    October 2007
55. DORES GM , Anderson WF, Curtis RE, Landgren O, et al
    Chronic lymphocytic leukaemia and small lymphocytic lymphoma: overview of the descriptive epidemiology.
    Br J Haematol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
56. SHANAFELT TD , Bowen D, Venkat C, Slager SL, et al
    Quality of life in chronic lymphocytic leukemia: an international survey of 1482 patients.
    Br J Haematol. 2007;139:255-64.
    PubMed     Related articles    Abstract available
    
    
    
57. PARNES A , Bifulco C, Vanasse GJ
    A novel regimen incorporating the concomitant administration of fludarabine and alemtuzumab for the treatment of refractory adult acute lymphoblastic leukaemia: a report of three cases.
    Br J Haematol. 2007;139:164-5.
    PubMed     Related articles   
    
    
    
58. ARBER C , Bertrand G, Halter J, Boehlen F, et al
    Platelet refractoriness due to combined anti-HLA and anti-HPA-5a alloantibodies: clinical management during myeloablative allogeneic HSCT and development of a quantitative MAIPA assay.
    Br J Haematol. 2007;139:159-61.
    PubMed     Related articles   
    
    
    
59. WALSBY EJ , Gilkes AF, Tonks A, Darley RL, et al
    FUS expression alters the differentiation response to all-trans retinoic acid in NB4 and NB4R2 cells.
    Br J Haematol. 2007;139:94-7.
    PubMed     Related articles    Abstract available
    
    
    
60. ESTES DA , Lovato DM, Khawaja HM, Winter SS, et al
    Genetic alterations determine chemotherapy resistance in childhood T-ALL: modelling in stage-specific cell lines and correlation with diagnostic patient samples.
    Br J Haematol. 2007;139:20-30.
    PubMed     Related articles    Abstract available
    
    
    
61. HUGHES C , Patterson K, Murray M
    Avascular necrosis of the femoral head in childhood chronic myeloid leukaemia.
    Br J Haematol. 2007;139:1.
    PubMed     Related articles   
    
    
    
62. BARTAKKE S , Abdelhaleem M, Abla O
    Childhood acute lymphoblastic leukaemia simulating multifocal osteomyelitis.
    Br J Haematol. 2007;139:2.
    PubMed     Related articles   
    
    
    
63. MORRIS ES , Vora A
    Remission induction with single agent Rituximab in a child with multiply relapsed precursor-B ALL.
    Br J Haematol. 2007;139:344-5.
    PubMed     Related articles   
    
    
    
64. NEBRAL K , Konig M, Harder L, Siebert R, et al
    Identification of PML as novel PAX5 fusion partner in childhood acute lymphoblastic leukaemia.
    Br J Haematol. 2007;139:269-74.
    PubMed     Related articles    Abstract available
    
    
    
65. KHARFAN-DABAJA MA , Kumar A, Behera M, Djulbegovic B, et al
    Systematic review of high dose chemotherapy and autologous haematopoietic stem cell transplantation for chronic lymphocytic leukaemia: what is the published evidence?
    Br J Haematol. 2007;139:234-42.
    PubMed     Related articles    Abstract available
    
    
    
66. RICCIONI R , Senese M, Diverio D, Riti V, et al
    M4 and M5 acute myeloid leukaemias display a high sensitivity to Bortezomib-mediated apoptosis.
    Br J Haematol. 2007;139:194-205.
    PubMed     Related articles    Abstract available
    
    
    
67. MCGETTRICK AF , O'Neill LA
    Toll-like receptors: key activators of leucocytes and regulator of haematopoiesis.
    Br J Haematol. 2007;139:185-93.
    PubMed     Related articles    Abstract available
    
    
    September 2007
68. MANN G , Attarbaschi A, Burkhardt B, Niggli F, et al
    Clinical characteristics and treatment outcome of infants with non-Hodgkin lymphoma.
    Br J Haematol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
69. BOAG JM , Beesley AH, Firth MJ, Freitas JR, et al
    High expression of connective tissue growth factor in pre-B acute lymphoblastic leukaemia.
    Br J Haematol. 2007;138:740-8.
    PubMed     Related articles    Abstract available
    
    
    
70. WILLIMOTT S , Baou M, Naresh K, Wagner SD, et al
    CD154 induces a switch in pro-survival Bcl-2 family members in chronic lymphocytic leukaemia.
    Br J Haematol. 2007;138:721-32.
    PubMed     Related articles    Abstract available
    
    
    
71. DENNISS FA , Breslin A, Ingram W, Hardwick NR, et al
    The leukaemia-associated antigen, SSX2IP, is expressed during mitosis on the surface of myeloid leukaemia cells.
    Br J Haematol. 2007;138:668-9.
    PubMed     Related articles   
    
    
    
72. OBAMA K , Kubota R, Tara M, Furukawa Y, et al
    Killer cell immunoglobulin-like receptor/3DL2 expression in adult T-cell leukaemia.
    Br J Haematol. 2007;138:666-7.
    PubMed     Related articles   
    
    
    
73. FLOTHO C , Paulun A, Batz C, Niemeyer CM, et al
    AKAP12, a gene with tumour suppressor properties, is a target of promoter DNA methylation in childhood myeloid malignancies.
    Br J Haematol. 2007;138:644-50.
    PubMed     Related articles    Abstract available
    
    
    
74. SUZUKI R , Onizuka M, Kojima M, Shimada M, et al
    Preferential hypermethylation of the Dickkopf-1 promoter in core-binding factor leukaemia.
    Br J Haematol. 2007;138:624-31.
    PubMed     Related articles    Abstract available
    
    
    
75. KIM KT , Baird K, Davis S, Piloto O, et al
    Constitutive Fms-like tyrosine kinase 3 activation results in specific changes in gene expression in myeloid leukaemic cells.
    Br J Haematol. 2007;138:603-15.
    PubMed     Related articles    Abstract available
    
    
    
76. KNAPPER S
    FLT3 inhibition in acute myeloid leukaemia.
    Br J Haematol. 2007;138:687-99.
    PubMed     Related articles    Abstract available
    
    
    
77. SERRAVALLE S , Purgato S, Melchionda F, Astolfi A, et al
    Trisomy 11 with MLL-PTD in a case of infant AML M0.
    Br J Haematol. 2007;138:817-9.
    PubMed     Related articles   
    
    
    August 2007
78. GANGAT N , Strand J, Li CY, Wu W, et al
    Leucocytosis in polycythaemia vera predicts both inferior survival and leukaemic transformation.
    Br J Haematol. 2007;138:354-8.
    PubMed     Related articles    Abstract available
    
    
    
79. KHAN NI , Bradstock KF, Bendall LJ
    Activation of Wnt/beta-catenin pathway mediates growth and survival in B-cell progenitor acute lymphoblastic leukaemia.
    Br J Haematol. 2007;138:338-48.
    PubMed     Related articles    Abstract available
    
    
    
80. RASAIYAAH J , Yong K, Katz DR, Kellam P, et al
    Dendritic cells and myeloid leukaemias: plasticity and commitment in cell differentiation.
    Br J Haematol. 2007;138:281-90.
    PubMed     Related articles    Abstract available
    
    
    
81. LAVASTRE V , Binet F, Moisan E, Chiasson S, et al
    Viscum album agglutinin-I induces degradation of cytoskeletal proteins in leukaemia PLB-985 cells differentiated toward neutrophils: cleavage of non-muscle myosin heavy chain-IIA by caspases.
    Br J Haematol. 2007;138:545-54.
    PubMed     Related articles    Abstract available
    
    
    
82. VENKATACHALAPATHY S , Crowe J, Gray A
    Atypical presentation of varicella zoster in a patient on alemtuzumab.
    Br J Haematol. 2007;138:406.
    PubMed     Related articles   
    
    
    
83. LIM ZY , Pearce L, Ho AY, Barber L, et al
    Delayed attainment of full donor chimaerism following alemtuzumab-based reduced-intensity conditioning haematopoeitic stem cell transplantation for acute myeloid leukaemia and myelodysplastic syndromes is associated with improved outcomes.
    Br J Haematol. 2007;138:517-26.
    PubMed     Related articles    Abstract available
    
    
    
84. PAYNE JH , Vora AJ
    Thrombosis and acute lymphoblastic leukaemia.
    Br J Haematol. 2007;138:430-45.
    PubMed     Related articles    Abstract available
    
    
    
85. YANADA M , Huang X, Garcia-Manero G, O'brien S, et al
    Effect of haematological improvement on survival in patients given targeted therapy as initial treatment of acute myeloid leukaemia or high-risk myelodysplastic syndrome.
    Br J Haematol. 2007;138:555-7.
    PubMed     Related articles   
    
    
    
86. KAPLINSKY C , Trakhtenbrot L, Izraeli S
    Could rhG-CSF induction of tetraploidy contribute to leukemogenesis in healthy donors?
    Br J Haematol. 2007;138:558.
    PubMed     Related articles   
    
    
    July 2007
87. PFEIFFER M , Schumm M, Feuchtinger T, Dietz K, et al
    Intensity of HLA class I expression and KIR-mismatch determine NK-cell mediated lysis of leukaemic blasts from children with acute lymphatic leukaemia.
    Br J Haematol. 2007;138:97-100.
    PubMed     Related articles    Abstract available
    
    
    
88. DAENEN S , van Imhoff GW, de Wolf JT, Vellenga E, et al
    A 'pre-induction course' with non-cross-reacting cytostatic drugs for rapid tumour load reduction improves outcome in adult acute lymphoblastic leukaemia.
    Br J Haematol. 2007;138:275-7.
    PubMed     Related articles   
    
    
    
89. SELLMANN L , Gesk S, Walter C, Ritgen M, et al
    Trisomy 19 is associated with trisomy 12 and mutated IGHV genes in B-chronic lymphocytic leukaemia.
    Br J Haematol. 2007;138:217-20.
    PubMed     Related articles    Abstract available
    
    
    
90. ARIBI A , Bueso-Ramos C, Estey E, Estrov Z, et al
    Biphenotypic acute leukaemia: a case series.
    Br J Haematol. 2007;138:213-6.
    PubMed     Related articles    Abstract available
    
    
    
91. SEBTI Y , Le Maux A, Gros F, De Guibert S, et al
    Expression of functional soluble human leucocyte antigen-G molecules in lymphoproliferative disorders.
    Br J Haematol. 2007;138:202-12.
    PubMed     Related articles    Abstract available
    
    
    
92. PAULSSON K , Jonson T, Ora I, Olofsson T, et al
    Characterisation of genomic translocation breakpoints and identification of an alternative TCF3/PBX1 fusion transcript in t(1;19)(q23;p13)-positive acute lymphoblastic leukaemias.
    Br J Haematol. 2007;138:196-201.
    PubMed     Related articles    Abstract available
    
    
    
93. CLAVIO M , Vignolo L, Albarello A, Varaldo R, et al
    Adding low-dose gemtuzumab ozogamicin to fludarabine, Ara-C and idarubicin (MY-FLAI) may improve disease-free and overall survival in elderly patients with non-M3 acute myeloid leukaemia: results of a prospective, pilot, multi-centre trial and comparison
    Br J Haematol. 2007;138:186-95.
    PubMed     Related articles    Abstract available
    
    
    
94. FENG H , Langenau DM, Madge JA, Quinkertz A, et al
    Heat-shock induction of T-cell lymphoma/leukaemia in conditional Cre/lox-regulated transgenic zebrafish.
    Br J Haematol. 2007;138:169-75.
    PubMed     Related articles    Abstract available
    
    
    
95. LEVENGA TH , Timmer-Bonte JN
    Review of the value of colony stimulating factors for prophylaxis of febrile neutropenic episodes in adult patients treated for haematological malignancies.
    Br J Haematol. 2007;138:146-52.
    PubMed     Related articles    Abstract available
    
    
    
96. GIANNOUTSOS I , Rosenfeld D
    Bone marrow lipofuscin in a patient with acute myeloid leukaemia and extensive marrow necrosis.
    Br J Haematol. 2007;138:129.
    PubMed     Related articles   
    
    
    June 2007
97. MEISEL R , Toschke AM, Heiligensetzer C, Dilloo D, et al
    Increased risk for invasive pneumococcal diseases in children with acute lymphoblastic leukaemia.
    Br J Haematol. 2007;137:457-60.
    PubMed     Related articles    Abstract available
    
    
    
98. AUER RL , Riaz S, Cotter FE
    The 13q and 11q B-cell chronic lymphocytic leukaemia-associated regions derive from a common ancestral region in the zebrafish.
    Br J Haematol. 2007;137:443-53.
    PubMed     Related articles    Abstract available
    
    
    
99. BALDUS CD , Mrozek K, Marcucci G, Bloomfield CD, et al
    Clinical outcome of de novo acute myeloid leukaemia patients with normal cytogenetics is affected by molecular genetic alterations: a concise review.
    Br J Haematol. 2007;137:387-400.
    PubMed     Related articles    Abstract available
    
    
    
100. GIRALT SA , Arora M, Goldman JM, Lee SJ, et al
     Impact of imatinib therapy on the use of allogeneic haematopoietic progenitor cell transplantation for the treatment of chronic myeloid leukaemia.
     Br J Haematol. 2007;137:461-7.
     PubMed     Related articles    Abstract available
     
     
     
101. PAVLU J , Andreasson C, Chuah C, Kaeda J, et al
     Dual inhibition of ras and bcr-abl signalling pathways in chronic myeloid leukaemia: a phase I/II study in patients in complete haematological remission.
     Br J Haematol. 2007;137:423-8.
     PubMed     Related articles    Abstract available
     
     
     
102. DALAL BI , Bruyere H, Barnett MJ
     Significance of persistent Auer rods and cytogenetic abnormality after first cycle of therapy for acute promyelocytic leukaemia.
     Br J Haematol. 2007;137:385.
     PubMed     Related articles   
     
     
     
103. RUJKIJYANONT P , Beyene J, Wei K, Khan F, et al
     Leukaemia-related gene expression in bone marrow cells from patients with the preleukaemic disorder Shwachman-Diamond syndrome.
     Br J Haematol. 2007;137:537-44.
     PubMed     Related articles    Abstract available
     
     
     
104. SEEDHOUSE C , Russell N
     Advances in the understanding of susceptibility to treatment-related acute myeloid leukaemia.
     Br J Haematol. 2007;137:513-29.
     PubMed     Related articles    Abstract available
     
     
     
105. LAWRIE CH
     MicroRNAs and haematology: small molecules, big function.
     Br J Haematol. 2007;137:503-12.
     PubMed     Related articles    Abstract available
     
     
     
106. DILHUYDY MS , Jouary T, Demeaux H, Ravaud A, et al
     Cutaneous cryptococcosis with alemtuzumab in a patient treated for chronic lymphocytic leukaemia.
     Br J Haematol. 2007;137:490.
     PubMed     Related articles   
     
     
     May 2007
107. FERNANDES J , Rocha V, Robin M, de Latour RP, et al
     Second transplant with two unrelated cord blood units for early graft failure after haematopoietic stem cell transplantation.
     Br J Haematol. 2007;137:248-51.
     PubMed     Related articles    Abstract available
     
     
     
108. MORICE WG , Jevremovic D, Hanson CA
     The expression of the novel cytotoxic protein granzyme M by large granular lymphocytic leukaemias of both T-cell and NK-cell lineage: an unexpected finding with implications regarding the pathobiology of these disorders.
     Br J Haematol. 2007;137:237-9.
     PubMed     Related articles    Abstract available
     
     
     
109. HAYASHI M , Kondoh K, Nakata Y, Kinoshita A, et al
     Establishment of a novel childhood acute myeloid leukaemia cell line, KOPM-88, containing partial tandem duplication of the MLL gene and an in vivo model for childhood acute myeloid leukaemia using NOD/SCID mice.
     Br J Haematol. 2007;137:221-32.
     PubMed     Related articles    Abstract available
     
     
     
110. KEITH T , Araki Y, Ohyagi M, Hasegawa M, et al
     Regulation of angiogenesis in the bone marrow of myelodysplastic syndromes transforming to overt leukaemia.
     Br J Haematol. 2007;137:206-15.
     PubMed     Related articles    Abstract available
     
     
     
111. HOWARD MR , Dickinson H
     Haemophagocytosis in acute myeloid leukaemia t(8;16).
     Br J Haematol. 2007;137:180.
     PubMed     Related articles   
     
     
     
112. SHVIDEL L , Sigler E, Shtalrid M, Berrebi A, et al
     Hybrid eosinophilic-basophilic acute myeloid leukaemia diagnosed by electron microscopy.
     Br J Haematol. 2007;137:381-3.
     PubMed     Related articles   
     
     
     
113. KHOURI IF , Saliba RM, Admirand J, O'Brien S, et al
     Graft-versus-leukaemia effect after non-myeloablative haematopoietic transplantation can overcome the unfavourable expression of ZAP-70 in refractory chronic lymphocytic leukaemia.
     Br J Haematol. 2007;137:355-63.
     PubMed     Related articles    Abstract available
     
     
     
114. DE VITA S , Mulligan C, McElwaine S, Dagna-Bricarelli F, et al
     Loss-of-function JAK3 mutations in TMD and AMKL of Down syndrome.
     Br J Haematol. 2007;137:337-41.
     PubMed     Related articles    Abstract available
     
     
     
115. GOTTARDO NG , Hoffmann K, Beesley AH, Freitas JR, et al
     Identification of novel molecular prognostic markers for paediatric T-cell acute lymphoblastic leukaemia.
     Br J Haematol. 2007;137:319-28.
     PubMed     Related articles    Abstract available
     
     
     
116. KORVER W , Singh S, Liu S, Zhao X, et al
     The lymphoid cell surface receptor NTB-A: a novel monoclonal antibody target for leukaemia and lymphoma therapeutics.
     Br J Haematol. 2007;137:307-18.
     PubMed     Related articles    Abstract available
     
     
     
117. BURGER JA , Burkle A
     The CXCR4 chemokine receptor in acute and chronic leukaemia: a marrow homing receptor and potential therapeutic target.
     Br J Haematol. 2007;137:288-96.
     PubMed     Related articles    Abstract available
     
     
     
118. RAMASAMY K , Hayden J, Lim Z, Mufti GJ, et al
     Successful pregnancies involving men with chronic myeloid leukaemia on imatinib therapy.
     Br J Haematol. 2007;137:374-5.
     PubMed     Related articles   
     
     
     
119. WESTERMANN J , Kopp J, van Lessen A, Hecker AC, et al
     Vaccination with autologous non-irradiated dendritic cells in patients with bcr/abl+ chronic myeloid leukaemia.
     Br J Haematol. 2007;137:297-306.
     PubMed     Related articles    Abstract available
     
     
     
120. HALSEY C , Fisher C, Strathdee G, Gibson B, et al
     GATA1 mutational analysis in chronic myeloid leukaemia.
     Br J Haematol. 2007;137:375-6.
     PubMed     Related articles   
     
     
     
121. SO CC , Wan TS, Yip SF, Ma SK, et al
     Can morphological assessment limit the use of specific genetic testing to exclude chronic myeloid leukaemia?
     Br J Haematol. 2007;137:377.
     PubMed     Related articles   
     
     
     April 2007
122. TAKEUCHI S , Hofmann WK, Tsukasaki K, Takeuchi N, et al
     Loss of H19 imprinting in adult T-cell leukaemia/lymphoma.
     Br J Haematol. 2007;.
     PubMed     Related articles   
     
     
     
123. NG D , Toure O, Fontaine L, McMaster ML, et al
     No association of ARLTS1 polymorphisms and risk for familial chronic lymphocytic leukaemia.
     Br J Haematol. 2007;137:173-5.
     PubMed     Related articles   
     
     
     
124. MEHTA PA , Eapen M, Klein JP, Gandham S, et al
     Interleukin-1 alpha genotype and outcome of unrelated donor haematopoietic stem cell transplantation for chronic myeloid leukaemia.
     Br J Haematol. 2007;137:152-7.
     PubMed     Related articles    Abstract available
     
     
     
125. PARRY-JONES N , Matutes E, Morilla R, Brito-Babapulle V, et al
     Cytogenetic abnormalities additional to t(11;14) correlate with clinical features in leukaemic presentation of mantle cell lymphoma, and may influence prognosis: a study of 60 cases by FISH.
     Br J Haematol. 2007;137:117-24.
     PubMed     Related articles    Abstract available
     
     
     
126. BEESLEY AH , Palmer ML, Ford J, Weller RE, et al
     In vitro cytotoxicity of nelarabine, clofarabine and flavopiridol in paediatric acute lymphoblastic leukaemia.
     Br J Haematol. 2007;137:109-16.
     PubMed     Related articles    Abstract available
     
     
     
127. DAWSON MA , Whitehead S
     Mature neutrophils with multiple Auer rods: a rarity in normal karyotype acute myeloid leukaemia.
     Br J Haematol. 2007;137:86.
     PubMed     Related articles   
     
     
     
128. GIRODON F , Bergoin E, Couillault G, Deny MH, et al
     Spontaneous macrophage colony-forming units in juvenile myelomonocytic leukaemia.
     Br J Haematol. 2007;137:85.
     PubMed     Related articles   
     
     
     
129. CONFER DL , Miller JP
     Long-term safety of filgrastim (rhG-CSF) administration.
     Br J Haematol. 2007;137:77-8.
     PubMed     Related articles       Free Full Text
     
     
     
130. LI L , Piloto O, Kim KT, Ye Z, et al
     FLT3/ITD expression increases expansion, survival and entry into cell cycle of human haematopoietic stem/progenitor cells.
     Br J Haematol. 2007;137:64-75.
     PubMed     Related articles    Abstract available
     
     
     
131. BOECKX N , Renard M, Uyttebroeck A
     Acute monocytic leukaemia with histiocytic features.
     Br J Haematol. 2007;137:2.
     PubMed     Related articles   
     
     
     March 2007
132. LIU KZ , Xu M, Scott DA
     Biomolecular characterisation of leucocytes by infrared spectroscopy.
     Br J Haematol. 2007;136:713-22.
     PubMed     Related articles    Abstract available
     
     
     
133. FOZZA C , Szydlo RM, Abdel-Rehim MM, Nadal E, et al
     Factors for graft-versus-host disease after donor lymphocyte infusions with an escalating dose regimen: lack of association with cell dose.
     Br J Haematol. 2007;136:833-6.
     PubMed     Related articles    Abstract available
     
     
     
134. YING J , Gao Z, Li H, Srivastava G, et al
     Frequent epigenetic silencing of protocadherin 10 by methylation in multiple haematologic malignancies.
     Br J Haematol. 2007;136:829-32.
     PubMed     Related articles    Abstract available
     
     
     
135. STAPNES C , Doskeland AP, Hatfield K, Ersvaer E, et al
     The proteasome inhibitors bortezomib and PR-171 have antiproliferative and proapoptotic effects on primary human acute myeloid leukaemia cells.
     Br J Haematol. 2007;136:814-28.
     PubMed     Related articles    Abstract available
     
     
     
136. BOBADILLA D , Enriquez EL, Alvarez G, Gaytan P, et al
     An interphase fluorescence in situ hybridisation assay for the detection of 3q26.2/EVI1 rearrangements in myeloid malignancies.
     Br J Haematol. 2007;136:806-13.
     PubMed     Related articles    Abstract available
     
     
     
137. BORTHAKUR G , O'Brien S, Wierda WG, Thomas DA, et al
     Immune anaemias in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab--incidence and predictors.
     Br J Haematol. 2007;136:800-5.
     PubMed     Related articles    Abstract available
     
     
     
138. TAN DC , Koh LP, Tan PH
     Computed tomography findings in a patient with severe graft-versus-host disease of the gut.
     Br J Haematol. 2007;136:768.
     PubMed     Related articles   
     
     
     February 2007
139. GUINN BA , Tobal K, Mills KI
     Comparison of the survival implications of tumour-associated versus cancer-testis antigen expression in acute myeloid leukaemia.
     Br J Haematol. 2007;136:510-2.
     PubMed     Related articles   
     
     
     
140. ISHIKAWA C , Matsuda T, Okudaira T, Tomita M, et al
     Bisphosphonate incadronate inhibits growth of human T-cell leukaemia virus type I-infected T-cell lines and primary adult T-cell leukaemia cells by interfering with the mevalonate pathway.
     Br J Haematol. 2007;136:424-32.
     PubMed     Related articles    Abstract available
     
     
     
141. CAUWENBERGHS S , Feijge MA, Theunissen E, Heemskerk JW, et al
     Novel methodology for assessment of prophylactic platelet transfusion therapy by measuring increased thrombus formation and thrombin generation.
     Br J Haematol. 2007;136:480-90.
     PubMed     Related articles    Abstract available
     
     
     
142. NYGREN MK , Dosen G, Hystad ME, Stubberud H, et al
     Wnt3A activates canonical Wnt signalling in acute lymphoblastic leukaemia (ALL) cells and inhibits the proliferation of B-ALL cell lines.
     Br J Haematol. 2007;136:400-13.
     PubMed     Related articles    Abstract available
     
     
     
143. NABHAN C , Coutre S, Hillmen P
     Minimal residual disease in chronic lymphocytic leukaemia: is it ready for primetime?
     Br J Haematol. 2007;136:379-92.
     PubMed     Related articles    Abstract available
     
     
     
144. LAURENT S , Palmisano GL, Martelli AM, Kato T, et al
     CTLA-4 expressed by chemoresistant, as well as untreated, myeloid leukaemia cells can be targeted with ligands to induce apoptosis.
     Br J Haematol. 2007;136:597-608.
     PubMed     Related articles    Abstract available
     
     
     
145. BOLUFER P , Collado M, Barragan E, Calasanz MJ, et al
     Profile of polymorphisms of drug-metabolising enzymes and the risk of therapy-related leukaemia.
     Br J Haematol. 2007;136:590-6.
     PubMed     Related articles    Abstract available
     
     
     
146. UCKUN F , Ozer Z, Vassilev A
     Bruton's tyrosine kinase prevents activation of the anti-apoptotic transcription factor STAT3 and promotes apoptosis in neoplastic B-cells and B-cell precursors exposed to oxidative stress.
     Br J Haematol. 2007;136:574-89.
     PubMed     Related articles    Abstract available
     
     
     
147. GARNACHE-OTTOU F , Feuillard J, Saas P
     Plasmacytoid dendritic cell leukaemia/lymphoma: towards a well defined entity?
     Br J Haematol. 2007;136:539-48.
     PubMed     Related articles    Abstract available
     
     
     
148. GILES FJ , Borthakur G, Ravandi F, Faderl S, et al
     The haematopoietic cell transplantation comorbidity index score is predictive of early death and survival in patients over 60 years of age receiving induction therapy for acute myeloid leukaemia.
     Br J Haematol. 2007;136:624-7.
     PubMed     Related articles    Abstract available
     
     
     
149. ARBUTHNOT CD , Bradbury M, Darbyshire PJ
     Relapsing acute myeloid leukaemia manifesting as uveitis with hypopyon.
     Br J Haematol. 2007;136:520.
     PubMed     Related articles   
     
     
     January 2007
150. AGBALIKA F , Larghero J, Esperou H, Marais D, et al
     Epstein-Barr virus early-antigen antibodies before allogeneic haematopoietic stem cell transplantation as a marker of risk of post-transplant lymphoproliferative disorders.
     Br J Haematol. 2007;136:305-8.
     PubMed     Related articles    Abstract available
     
     
     
151. ABRAHAMSSON J , Clausen N, Gustafsson G, Hovi L, et al
     Improved outcome after relapse in children with acute myeloid leukaemia.
     Br J Haematol. 2007;136:229-236.
     PubMed     Related articles    Abstract available
     
     
     
152. PANAGOPOULOS I , Kerndrup G, Carlsen N, Strombeck B, et al
     Fusion of NUP98 and the SET binding protein 1 (SETBP1) gene in a paediatric acute T cell lymphoblastic leukaemia with t(11;18)(p15;q12).
     Br J Haematol. 2007;136:294-6.
     PubMed     Related articles    Abstract available
     
     
     
153. HAZLEHURST LA , Argilagos RF, Dalton WS
     Beta1 integrin mediated adhesion increases Bim protein degradation and contributes to drug resistance in leukaemia cells.
     Br J Haematol. 2007;136:269-75.
     PubMed     Related articles    Abstract available
     
     
     
154. RINGHOFFER M , Harsdorf S, Schmitt M, Wiesneth M, et al
     Reduced-intensity conditioning followed by T-cell depleted allogeneic stem cell transplantation for patients with chronic myeloid leukaemia and minimal residual disease at the time of transplant: high risk of molecular relapse.
     Br J Haematol. 2007;136:127-30.
     PubMed     Related articles    Abstract available
     
     
     
155. MALAGOLA M , Damiani D, Martinelli G, Michelutti A, et al
     Case-control study of multidrug resistance phenotype and response to induction treatment including or not fludarabine in newly diagnosed acute myeloid leukaemia patients.
     Br J Haematol. 2007;136:87-95.
     PubMed     Related articles    Abstract available
     
     
     
156. ELMAAGACLI AH , Koldehoff M, Zakrzewski JL, Steckel NK, et al
     Growth factor-independent 1B gene (GFI1B) is overexpressed in erythropoietic and megakaryocytic malignancies and increases their proliferation rate.
     Br J Haematol. 2007;136:212-9.
     PubMed     Related articles    Abstract available
     
     
     
157. DI NISIO M , Barbui T, Di Gennaro L, Borrelli G, et al
     The haematocrit and platelet target in polycythemia vera.
     Br J Haematol. 2007;136:249-59.
     PubMed     Related articles    Abstract available
     
     
     
158. NEARMAN ZP , Wlodarski M, Jankowska AM, Howe E, et al
     Immunogenetic factors determining the evolution of T-cell large granular lymphocyte leukaemia and associated cytopenias.
     Br J Haematol. 2007;136:237-48.
     PubMed     Related articles    Abstract available
     
     
     
159. ROBERTS L , Lucas G, Green L, Lindsay J, et al
     Autoimmune neutropenia following therapy for chronic lymphocytic leukaemia: a report of three cases.
     Br J Haematol. 2007;136:348-9.
     PubMed     Related articles   
     
     
     
160. HUH YO , Abruzzo LV, Rassidakis GZ, Parry-Jones N, et al
     The t(14;19)(q32;q13)-positive small B-cell leukaemia: a clinicopathologic and cytogenetic study of seven cases.
     Br J Haematol. 2007;136:220-8.
     PubMed     Related articles    Abstract available
     
     
     
161. SADAKANE Y , Zaitsu M, Nishi M, Sugita K, et al
     Expression and production of aberrant PAX5 with deletion of exon 8 in B-lineage acute lymphoblastic leukaemia of children.
     Br J Haematol. 2007;136:297-300.
     PubMed     Related articles    Abstract available
     
     
     
162. VAN DER HOLT B , Breems DA, Berna Beverloo H, van den Berg E, et al
     Various distinctive cytogenetic abnormalities in patients with acute myeloid leukaemia aged 60 years and older express adverse prognostic value: results from a prospective clinical trial.
     Br J Haematol. 2007;136:96-105.
     PubMed     Related articles    Abstract available
     
     
     
163. AUER RL , Dighiero G, Goldin LR, Syndercombe-Court D, et al
     Trinucleotide repeat dynamic mutation identifying susceptibility in familial and sporadic chronic lymphocytic leukaemia.
     Br J Haematol. 2007;136:73-9.
     PubMed     Related articles    Abstract available
     
     
     
164. EICHHORST BF , Busch R, Schweighofer C, Wendtner CM, et al
     Due to low infection rates no routine anti-infective prophylaxis is required in younger patients with chronic lymphocytic leukaemia during fludarabine-based first line therapy.
     Br J Haematol. 2007;136:63-72.
     PubMed     Related articles    Abstract available
     
     
     
165. BOILY G , Larose J, Langlois S, Sinnett D, et al
     Identification of transcripts modulated by ETV6 expression.
     Br J Haematol. 2007;136:48-62.
     PubMed     Related articles    Abstract available
     
     
     December 2006
166. MISSEN MA , Haylock D, Whitty G, Medcalf RL, et al
     Stage specific gene expression of serpins and their cognate proteases during myeloid differentiation.
     Br J Haematol. 2006;135:715-24.
     PubMed     Related articles    Abstract available
     
     
     
167. IMAI N , Shikami M, Miwa H, Suganuma K, et al
     t(8;21) acute myeloid leukaemia cells are dependent on vascular endothelial growth factor (VEGF)/VEGF receptor type2 pathway and phosphorylation of Akt.
     Br J Haematol. 2006;135:673-82.
     PubMed     Related articles    Abstract available
     
     
     
168. WHITLOCK JA
     Down syndrome and acute lymphoblastic leukaemia.
     Br J Haematol. 2006;135:595-602.
     PubMed     Related articles    Abstract available
     
     
     
169. BENNETT CL , Evens AM, Andritsos LA, Balasubramanian L, et al
     Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project.
     Br J Haematol. 2006;135:642-50.
     PubMed     Related articles    Abstract available
     
     
     
170. GOLDMAN JM , Madrigal JA, Pamphilon D
     Possible harmful effects of short course granulocyte colony-stimulating factor in normal donors.
     Br J Haematol. 2006;135:651-2.
     PubMed     Related articles   
     
     
     
171. ROVIDA E , Gozzini A, Barbetti V, Giuntoli S, et al
     The c-Jun-N-terminal-Kinase inhibitor SP600125 enhances the butyrate derivative D1-induced apoptosis via caspase 8 activation in Kasumi 1 t(8;21) acute myeloid leukaemia cells.
     Br J Haematol. 2006;135:653-9.
     PubMed     Related articles    Abstract available
     
     
     November 2006
172. HART J , Robert Turner A, Larratt L, Russell J, et al
     Transmission of a follicular lymphoma by allogeneic bone marrow transplantation - evidence to support the existence of lymphoma progenitor cells.
     Br J Haematol. 2006;.
     PubMed     Related articles   
     
     
     
173. ICHIKAWA H , Tanabe K, Mizushima H, Hayashi Y, et al
     Common gene expression signatures in t(8;21)- and inv(16)-acute myeloid leukaemia.
     Br J Haematol. 2006;135:336-47.
     PubMed     Related articles    Abstract available
     
     
     
174. CHEN IM , Chakerian A, Devidas M, Borowitz MJ, et al
     Resolution of ambiguous low-level positive quantitative polymerase chain reaction results in TEL-AML1 positive ALL using a post-PCR fluorescent oligoligation method.
     Br J Haematol. 2006;135:358-61.
     PubMed     Related articles    Abstract available
     
     
     
175. WU SJ , Yao M, Chou WC, Tang JL, et al
     Clinical implications of SOCS1 methylation in myelodysplastic syndrome.
     Br J Haematol. 2006;135:317-23.
     PubMed     Related articles    Abstract available
     
     
     
176. CZIBERE A , Prall WC, Zerbini LF, Jager M, et al
     Exisulind induces apoptosis in advanced myelodysplastic syndrome (MDS) and acute myeloid leukaemia/MDS.
     Br J Haematol. 2006;135:355-7.
     PubMed     Related articles    Abstract available
     
     
     
177. AKATSUKA Y , Torikai H, Inamoto Y, Tsujimura K, et al
     Bone marrow may be a reservoir of long-lived memory T cells specific for minor histocompatibility antigen.
     Br J Haematol. 2006;135:413-4.
     PubMed     Related articles   
     
     
     
178. KARRMAN K , Forestier E, Andersen MK, Autio K, et al
     High incidence of the ETV6/RUNX1 fusion gene in paediatric precursor B-cell acute lymphoblastic leukaemias with trisomy 21 as the sole cytogenetic change: a Nordic series of cases diagnosed 1989-2005.
     Br J Haematol. 2006;135:352-4.
     PubMed     Related articles    Abstract available
     
     
     
179. GRANDAGE VL , Everington T, Linch DC, Khwaja A, et al
     Go6976 is a potent inhibitor of the JAK 2 and FLT3 tyrosine kinases with significant activity in primary acute myeloid leukaemia cells.
     Br J Haematol. 2006;135:303-16.
     PubMed     Related articles    Abstract available
     
     
     
180. LEUPIN N , Kuhn A, Hugli B, Grob TJ, et al
     Gene expression profiling reveals consistent differences between clinical samples of human leukaemias and their model cell lines.
     Br J Haematol. 2006;135:520-3.
     PubMed     Related articles    Abstract available   Free Full Text
     
     
     
181. UCKUN FM , Morar S, Qazi S
     Vinorelbine-based salvage chemotherapy for therapy-refractory aggressive leukaemias.
     Br J Haematol. 2006;135:500-8.
     PubMed     Related articles    Abstract available
     
     
     
182. MILLIGAN DW , Grimwade D, Cullis JO, Bond L, et al
     Guidelines on the management of acute myeloid leukaemia in adults.
     Br J Haematol. 2006;135:450-74.
     PubMed     Related articles   
     
     
     
183. MORRIS KL , Adams JA, Liu JA
     Effect of gemtuzumab ozogamicin on acute myeloid leukemia blast cells in vitro, as a single agent and combined with other cytotoxic cells.
     Br J Haematol. 2006;135:509-12.
     PubMed     Related articles    Abstract available
     
     
     
184. MONTES-ARES O , Moya-Quiles MR, Montes-Casado M, Guerra-Perez N, et al
     Human leucocyte antigen-C in B chronic lymphocytic leukaemia.
     Br J Haematol. 2006;135:517-9.
     PubMed     Related articles    Abstract available
     
     
     
185. CLOOSEN S , Gratama J, van Leeuwen EB, Senden-Gijsbers BL, et al
     Cancer specific Mucin-1 glycoforms are expressed on multiple myeloma.
     Br J Haematol. 2006;135:513-6.
     PubMed     Related articles    Abstract available
     
     
     
186. SCHOUMANS J , Johansson B, Corcoran M, Kuchinskaya E, et al
     Characterisation of dic(9;20)(p11-13;q11) in childhood B-cell precursor acute lymphoblastic leukaemia by tiling resolution array-based comparative genomic hybridisation reveals clustered breakpoints at 9p13.2 and 20q11.2.
     Br J Haematol. 2006;135:492-9.
     PubMed     Related articles    Abstract available
     
     
     
187. REZVANY MR , Tehrani MJ, Karlsson C, Lundin J, et al
     Reconstitution of the T-cell repertoire following treatment with alemtuzumab (anti-CD52 monoclonal antibody) in patients with B-cell chronic lymphocytic leukaemia.
     Br J Haematol. 2006;135:475-85.
     PubMed     Related articles    Abstract available
     
     
     
188. BASECKE J , Whelan JT, Griesinger F, Bertrand FE, et al
     The MLL partial tandem duplication in acute myeloid leukaemia.
     Br J Haematol. 2006;135:438-49.
     PubMed     Related articles    Abstract available
     
     
     October 2006
189. THACHIL J , Mukherje K, Woodcock B
     Rituximab-induced haemorrhagic thrombocytopenia in a patient with hairy cell leukaemia.
     Br J Haematol. 2006;135:273-4.
     PubMed     Related articles   
     
     
     
190. LANCIOTTI M , D'Apolito M, Paolucci P, Dufour C, et al
     Chromosomal locus 19p13 as potential hotspot for aberrant gene expression in relapsed paediatric acute lymphoblastic leukaemia.
     Br J Haematol. 2006;135:274-5.
     PubMed     Related articles   
     
     
     
191. DONTI E , Zaccaria A, Bassetti A, Venti G, et al
     Occurrence of the same chromosome abnormalities in Ph+ and Ph- cells in chronic myeloid leukaemia. Evidence of a secondary origin of the Ph chromosome?
     Br J Haematol. 2006;135:265-6.
     PubMed     Related articles   
     
     
     
192. ROSSI D , Deambrogi C, Capello D, Cerri M, et al
     JAK2 V617F mutation in leukaemic transformation of philadelphia-negative chronic myeloproliferative disorders.
     Br J Haematol. 2006;135:267-8.
     PubMed     Related articles   
     
     
     
193. CYBULLA M , Kleber M, Walter KN, Kroeber SM, et al
     Is Fabry disease associated with leukaemia?
     Br J Haematol. 2006;135:264-5.
     PubMed     Related articles   
     
     
     
194. PRIMO D , Flores J, Quijano S, Sanchez ML, et al
     Impact of BCR/ABL gene expression on the proliferative rate of different subpopulations of haematopoietic cells in chronic myeloid leukaemia.
     Br J Haematol. 2006;135:43-51.
     PubMed     Related articles    Abstract available
     
     
     
195. BELOV L , Mulligan SP, Barber N, Woolfson A, et al
     Analysis of human leukaemias and lymphomas using extensive immunophenotypes from an antibody microarray.
     Br J Haematol. 2006;135:184-97.
     PubMed     Related articles    Abstract available
     
     
     
196. APPELBAUM FR , Kopecky KJ, Tallman MS, Slovak ML, et al
     The clinical spectrum of adult acute myeloid leukaemia associated with core binding factor translocations.
     Br J Haematol. 2006;135:165-73.
     PubMed     Related articles    Abstract available
     
     
     September 2006
197. KUCHENBAUER F , Schnittger S, Look T, Gilliland G, et al
     Identification of additional cytogenetic and molecular genetic abnormalities in acute myeloid leukaemia with t(8;21)/AML1-ETO.
     Br J Haematol. 2006;134:616-9.
     PubMed     Related articles    Abstract available
     
     
     
198. CHANG H , Yeung J, Xu W, Ning Y, et al
     Significant increase of CKS1B amplification from monoclonal gammopathy of undetermined significance to multiple myeloma and plasma cell leukaemia as demonstrated by interphase fluorescence in situ hybridisation.
     Br J Haematol. 2006;134:613-5.
     PubMed     Related articles    Abstract available
     
     
     
199. KOLITZ JE
     Current therapeutic strategies for acute myeloid leukaemia.
     Br J Haematol. 2006;134:555-72.
     PubMed     Related articles    Abstract available
     
     
     
200. PAN XY , Chen GQ, Cai L, Buscemi S, et al
     Anion exchanger 2 mediates the action of arsenic trioxide.
     Br J Haematol. 2006;134:491-9.
     PubMed     Related articles    Abstract available
     
     
     
201. KIM KT , Levis M, Small D
     Constitutively activated FLT3 phosphorylates BAD partially through pim-1.
     Br J Haematol. 2006;134:500-9.
     PubMed     Related articles    Abstract available
     
     
     
202. KUHLE S , Lau A, Bajzar L, Vegh P, et al
     Comparison of the anticoagulant effect of a direct thrombin inhibitor and a low molecular weight heparin in an acquired antithrombin deficiency in children with acute lymphoblastic leukaemia treated with L-asparaginase: an in vitro study.
     Br J Haematol. 2006;134:526-31.
     PubMed     Related articles    Abstract available
     
     
     June 2006
203. SEYMOUR JF
     101 years of McCrae's (not Auer's) rods.
     Br J Haematol. 2006;133:690.
     PubMed     Related articles   
     
     
     
204. MA W , Jilani I, Gorre M, Keating M, et al
     Plasma as a source of mRNA for determining IgV(H) mutation status in patients with chronic lymphocytic leukaemia.
     Br J Haematol. 2006;133:690-2.
     PubMed     Related articles   
     
     
     
205. AL-AHMARI A , Shah N, Sung L, Zipursky A, et al
     Long-term results of an ultra low-dose cytarabine-based regimen for the treatment of acute megakaryoblastic leukaemia in children with Down syndrome.
     Br J Haematol. 2006;133:646-8.
     PubMed     Related articles    Abstract available
     
     
     
206. PRIETO-SANCHEZ RM , Hernandez JA, Garcia JL, Gutierrez NC, et al
     Overexpression of the VAV proto-oncogene product is associated with B-cell chronic lymphocytic leukaemia displaying loss on 13q.
     Br J Haematol. 2006;133:642-5.
     PubMed     Related articles    Abstract available
     
     
     
207. CAUDILL JS , Sternberg AJ, Li CY, Tefferi A, et al
     C-terminal nucleophosmin mutations are uncommon in chronic myeloid disorders.
     Br J Haematol. 2006;133:638-41.
     PubMed     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: